cromakalim has been researched along with adenosine-5'-(n-ethylcarboxamide) in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bottrill, FE; Hiley, CR; Omar, R; White, R | 1 |
Jamal Mustafa, S; Ledent, C; Nayeem, MA; Ponnoth, DS; Tilley, SL | 1 |
2 other study(ies) available for cromakalim and adenosine-5'-(n-ethylcarboxamide)
Article | Year |
---|---|
Interaction of cyclic AMP modulating agents with levcromakalim in the relaxation of rat isolated mesenteric artery.
Topics: Adenosine-5'-(N-ethylcarboxamide); Animals; Bucladesine; Colforsin; Cromakalim; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Glyburide; In Vitro Techniques; Male; Mesenteric Arteries; Methoxamine; Rats; Rats, Wistar; Thionucleotides; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2000 |
CYP-epoxygenases contribute to A2A receptor-mediated aortic relaxation via sarcolemmal KATP channels.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Alcohol Oxidoreductases; Animals; Cromakalim; Decanoic Acids; Female; Glyburide; Hydroxy Acids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidoreductases; Phenethylamines; Pinacidil; Receptor, Adenosine A2A; Sarcolemma | 2012 |